Surgery of Breast Cancer Brain Metastasis at Joliot Curie Cancer Institute: About 4 Cases and Review of the Literature

To describe the place of surgery in therapeutic management of breast cancer brain metastasis at Joliot Curie Cancer Institute according to 4 cases. Age at diagnosis was 31, 48, 57 and 63 years. Patients were stage 2 and 3. Molecular were triple negative in 1 case, HER2 positive in 1 case and hormone positive in 2 cases. The median delay of brain metastasis occurrence was 20 months. Neoadjuvant radiotherapy was performed for 1 patient. Surgery of metastasis was complete for 1 patient and partial for 3 patients. No patient had adjuvant whole brain radiotherapy. The average survival time was 13 months.